Home/IPOs/AccretionPharmaceuticals

AccretionPharmaceuticals IPO

Accretion Pharmaceuticals Limited

IPO Doc

Start Date14-05-2025

Application Timing10am-5pm

Price Range₹96 - ₹101

Min Qty1200

Min. Investment₹121200

Listing DateNA

Close Date16-05-2025

About Accretion Pharmaceuticals Limited

Accretion Pharmaceuticals Limited, incorporated in 2012 and headquartered in Ahmedabad, Gujarat, is a fast-growing pharmaceutical company engaged in the manufacturing and marketing of high-quality healthcare products. The company produces a wide range of formulations including tablets, capsules, oral liquids, ointments, creams, gels, lotions, medicated shampoos, mouthwashes, dusting powders, and oral powders (sachets and dry syrups).

In addition to its own branded products, the company also offers contract manufacturing services, making it a reliable partner for both domestic and international pharmaceutical companies. Its manufacturing facility in Sanand, Gujarat, complies with stringent quality standards and holds ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005 certifications, emphasizing its commitment to quality, environmental sustainability, and food safety.

Accretion Pharmaceuticals has established a significant global presence, exporting its products to over 20 countries, particularly across Africa, Southeast Asia, and the Middle East.

Why To Invest in Accretion Pharmaceuticals Limited

Strong Financial Growth: The company has shown consistent revenue and profit growth over the past few years. For example, its profit after tax increased from 0.08 Cr in FY22 to 5.24 Cr (as of Dec 2024).

High Return Ratios: The Return on Equity (ROE) is at 72.47% and Return on Capital Employed (ROCE) is 36.73%, indicating strong operational efficiency.

Expanding Global Footprint: With exports to over 20 countries, Accretion Pharmaceuticals is rapidly scaling its international presence.

Use of IPO Proceeds for Growth: A significant portion of IPO funds will be used for capacity expansion, equipment modernization, and working capital, which can drive further revenue and margin growth.

Presence in High-Growth Sector: Being part of the pharmaceutical industry, the company benefits from growing demand for healthcare solutions in both domestic and export markets.

Financial Table

Period Ended	31 Dec 2024	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	39.99	27.05	20.58	17.74
Revenue	35.75	33.94	29.53	22.58
Profit After Tax	5.24	3.88	0.10	0.08
Net Worth	13.58	5.35	3.84	3.08
Reserves and Surplus	5.41	1.35	0.00	0.00
Total Borrowing	13.79	13.48	8.47	7.61

Strengths And Risks

Diversified Product Portfolio: Accretion Pharmaceuticals manufactures a wide range of pharmaceutical formulations, including tablets, capsules, liquids, ointments, and powders, catering to both domestic and international markets.

ISO-Certified Manufacturing Facility: The company’s production unit in Sanand, Gujarat, is accredited with ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005 certifications, ensuring adherence to quality and environmental standards.

Strong Financial Performance: With a Return on Equity (ROE) of 72.47% and consistent revenue growth, the company showcases robust financial health and profitability.

Strategic Use of IPO Proceeds: Funds raised through the IPO will be directed towards capacity expansion, modernization of existing infrastructure, and repayment of debts, which can enhance operational efficiency.

Expanding Global Reach: Accretion Pharmaceuticals has already established a presence in over 20 countries across Africa, Southeast Asia, and the Middle East, indicating strong export potential and global scalability.

High Debt Levels: The company has a Debt-to-Equity ratio of 2.52, indicating significant dependence on borrowings, which could impact financial flexibility and future growth.

Regulatory Dependence: As a pharmaceutical exporter, the business is subject to complex international regulatory approvals. Any changes or delays in compliance can affect operations and product launches.

SME Platform Listing: Being listed on the NSE SME platform, the stock may face lower liquidity and limited analyst coverage, which could impact investor participation and price discovery.

Exposure to Market Volatility: The company's share price post-listing may be influenced by sector-specific trends, government policies, and global market conditions, especially within the pharma industry.

FAQs

What is the Accretion Pharmaceuticals IPO date? +

What is the price band for the IPO? +

What is the minimum lot size and investment? +

What is the IPO size and type? +

Who is the registrar of the IPO? +

E-IPO

Get In On The Action EarlyBuy cheap, earn big. Discover IPOs with the highest growth potential early and invest now through Rupeezy to earn big in the future.

Explore Other Products

Rupeezy AppAdvanced charts, advanced Option Chain, instant pay-in & pay-out,margin .Learn More

Rupeezy <> TradingViewEnjoy top-class trading experience enhanced by advanced TradingView charts.Learn More

DockPortfolio analysis, pledge holdings, apply in IPOs & download reports Learn More

3rd Floor, Incubex INR4, 777c, 100 Feet Rd, HAL 2nd Stage, Indiranagar, Bengaluru, Karnataka 560038

0755-4268599, 0755-6693322

support@rupeezy.in

Download the Rupeezy App now

Products

NFO

Platform

Rupeezy <> TradingView

Partner App (MFD)

Partner Login

Features

Weekly MTF

Iceberg

MF Lab

Smart Explore

Business

Help

Company

Astha Credit & Securities Pvt Ltd NSE, BSE & MCX SEBI Reg No:

INZ000187932

Membership ID:

NSE - 12227 BSE-6844 MCX - 40000 NSDL-IN303420 CDSL-94500

CIN:

U65929MP2003PTC016241

SEBI Depository Participant Reg No:

IN-DP-611-2021

For any grievance contact:

grievance@rupeezy.in
0755-4268599

For cyber attack incident reporting:

gyanesh@rupeezy.in
9669695615

SEBI RA Registration:

INH000013332

AMFI Registration:

ARN-35911

Attention Investors:

Beware of fixed/guaranteed/regular returns/ capital protection schemes. Brokers or their authorized persons or any of their associates are not authorized to offer fixed/guaranteed/regular returns/ capital protection on your investment or authorized to enter into any loan agreement with you to pay interest on the funds offered by you. Please note that in case of default of a member claim for funds or securities given to the broker under any arrangement/ agreement of indicative return will not be accepted by the relevant Committee of the Exchange as per the approved norms.
Do not keep funds idle with the Stock Broker. Please note that your stock broker has to return the credit balance lying with them, within three working days in case you have not done any transaction within last 30 calendar days. Please note that in case of default of a Member, claim for funds and securities, without any transaction on the exchange will not be accepted by the relevant Committee of the Exchange as per the approved norms.
Check the frequency of accounts settlement opted for. If you have opted for running account, please ensure that your broker settles your account and, in any case, not later than once in 90 days (or 30 days if you have opted for 30 days settlement). In case of declaration of trading member as defaulter, the claims of clients against such defaulter member would be subject to norms for eligibility of claims for compensation from IPF to the clients of the defaulter member. These norms are available on Exchange website at following link: https://www.nseindia.com/invest/about-defaulter-section.
Brokers are not permitted to accept transfer of securities as margin. Securities offered as margin/ collateral MUST remain in the account of the client and can be pledged to the broker only by way of ‘margin pledge’, created in the Depository system. Clients are not permitted to place any securities with the broker or associate of the broker or authorized person of the broker for any reason. Broker can take securities belonging to clients only for settlement of securities sold by the client.
Always keep your contact details viz. Mobile number/Email ID updated with the stock broker. Email and mobile number is mandatory and you must provide the same to your broker for updation in Exchange records. You must immediately take up the matter with Stock Broker/Exchange if you are not receiving the messages from Exchange/Depositories regularly.
Don't ignore any emails/SMSs received from the Exchange for trades done by you. Verify the same with the Contract notes/Statement of accounts received from your broker and report discrepancy, if any, to your broker in writing immediately and if the Stock Broker does not respond, please take this up with the Exchange/Depositories forthwith.
Check messages sent by Exchanges on a weekly basis regarding funds and securities balances reported by the trading member, compare it with the weekly statement of account sent by broker and immediately raise a concern to the exchange if you notice a discrepancy.
Please do not transfer funds, for the purposes of trading to anyone, including an authorized person or an associate of the broker, other than a SEBI registered Stock broker.

Precautions for clients dealing in Options

Sharing of trading credentials i.e. login id & passwords including OTP’s is prohibited.
Trading in leveraged products like options without proper understanding could lead to losses. Please trade at your own risk.
Writing/ selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks could lead to losses.
Dealing in unsolicited tips through WhatsApp, Telegram, YouTube, Facebook, SMS, calls, etc should be avoided.
Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers should be avoided.

Awareness regarding guidelines regarding margin collection:

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020
Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge
Pay 20% upfront margin of the transaction value to trade in cash market segment
Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard
Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month

Advisory – KYC Compliance:

All investors are requested to take note that 6 KYC attributes i.e. Name, PAN, Address, Mobile Number, Email id and Income Range have been made mandatory. Investors availing custodian services will be additionally required to update the custodian details.
The last date to update KYC is on or before March 31, 2022.
Thereafter non-compliant trading accounts will be blocked for trading by the Exchange.
The non-compliant demat accounts will be frozen for debits by Depository Participant or Depository.
On submission of the necessary information to the stockbroker and updation of the same by the stockbroker in the Exchange systems and approval by the Exchange, the blocked trading accounts shall be unblocked by the Exchange on T+1 trading day.
The demat account shall be unfreezed once the investor submits the deficient KYC details and the same is captured by the depository participant in the depository system.
To ensure smooth settlement of trades, the investors are requested to ensure that both the trading and demat accounts are compliant with respect to the KYC requirement.
The investors are hereby requested to comply with the regulatory guidelines issued by Exchanges and Depositories from time to time with regard to KYC compliance and related requirements.
We do proprietary trading

Client Bank Account Details:

Sr. No	Name of Bank Account	Bank Account Number	IFSC Code
1	ASTHA CREDIT AND SECURITIES P LTD - USCNBA A/c	00620340000150	HDFC0000062

*Investors are requested to note that Stock broker Astha Credit and Securities Private Limited is permitted to receive/pay money from/to investor through designated bank accounts only named as client bank accounts. Stock broker Astha Credit and Securities Private Limited is also required to disclose these client bank accounts to Stock Exchange. Hence, you are requested to use following client bank accounts only for the purpose of dealings in your trading account with us. The details of these client bank accounts are also displayed by Stock Exchanges on their website under “Know/ Locate your Stock Broker.

1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in the investor's account. 2. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary.

Disclaimer:

Investment in the securities market is subject to market risks, read all the related documents carefully before investing.
Brokerage will not exceed SEBI prescribed limit.
Please refer to the Risk Disclosure Document issued by SEBI and go through the Rights and Obligations and Do's and Don'ts issued by Stock Exchanges and Depositories before trading on the Stock Exchanges.
For commodities derivatives please note that Commodities Derivatives are highly leveraged instruments.
Before investing in the asset class consider your investment objectives, level of experience and risk appetite carefully.
Mutual fund investments are subject to market risks, read all scheme related documents carefully. Mutual Funds are not an approved product of the Exchanges and any dispute related to this will not be dealt at Exchange platform. ACSPL is a Mutual fund distributor/s registered for Mutual Funds.

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL/CDSL on the same day......................issued in the interest of investors. We do Pro trading.

Client registration documents in Vernacular languages: Get Documents

Terms and Conditions | Privacy Policy | Investor Charter

Download the App Now!

AccretionPharmaceuticals IPO

About Accretion Pharmaceuticals Limited

Why To Invest in Accretion Pharmaceuticals Limited